Sun Pharmaceutical Industries Share Price Today - Live Blog for June 26, 2025

Sun Pharmaceutical Industries Ltd's share price has dropped by -0.22%, a development that warrants careful analysis. Presently trading at ₹1,666.00, investors are assessing whether this presents an opportunity or a risk.

Sun Pharmaceutical Industries Ltd share price surged by 0.16%. With its current market price standing at ₹1,670.60 per share, this stock is garnering increased attention from the investment community.

Following a noteworthy 0.02% increase, Sun Pharmaceutical Industries Ltd's shares are now trading at ₹1,668.00. When it comes to valuation, this stock has a PE ratio of 36.6700, with the industry PE ratio at 34.2321.

Sun Pharmaceutical Industries Ltd's share price rallied by 0.06%, reaching the current market price of ₹1,667.50. This surge is indicative of the stock's recent positive performance.

The stock of Sun Pharmaceutical Industries Ltd suffered a -0.10% drop, and it's now trading at ₹1,667.20 per share. Investors are assessing whether this decline represents a buying opportunity or a sign of ongoing challenges.

Demonstrating a commendable 0.14% gain, Sun Pharmaceutical Industries Ltd's share price is currently situated at ₹1,668.75. In terms of valuation, the stock maintains a PE ratio of 36.6700, while the industry PE ratio stands at 34.2321.

Following a noteworthy 0.03% increase, Sun Pharmaceutical Industries Ltd's shares are now trading at ₹1,666.80. When it comes to valuation, this stock has a PE ratio of 36.6700, with the industry PE ratio at 34.2321.

Sun Pharmaceutical Industries Ltd witnessed a notable 0.20% surge in its share price and is presently trading at ₹1,666.35, captivating the attention of market participants.

Sun Pharmaceutical Industries Ltd's share price has fallen by -0.10%, a situation worth noting. At present, the stock is trading at ₹1,662.50. Investors might find this a moment to reassess their positions. The stock's current Price-to-Earnings (PE) ratio stands at 36.6700, while the industry PE ratio is 34.2321.

Climbing steadily, Sun Pharmaceutical Industries Ltd shares have ascended by 0.12%, reaching the current market price of ₹1,664.20. This ascent signifies increased investor sentiment. The stock has an ROE of 15.1334% and debt to equity ratio of 0.0327.

Increased investor interest has propelled Sun Pharmaceutical Industries Ltd's stock to a significant 0.51% gain, with the share price now at ₹1,662.15. Notably, the stock's PE ratio stands at 36.6700, and its Return on Equity (ROE) is 15.1334%.

Sun Pharmaceutical Industries Ltd experienced a -0.53% dip in its share price and is currently trading at ₹1,654.05. The stock has a PE ratio of 36.6700, an ROE of 15.1334% and a debt to equity ratio of 0.0327.

After a notable 0.31% increase, Sun Pharmaceutical Industries Ltd's shares are now trading at ₹1,663.60. This surge signifies heightened investor interest in acquiring the stock. The stock has a debt to equity ratio of 0.0327 and an ROE of 15.1334%.

In a noteworthy development, Sun Pharmaceutical Industries Ltd witnessed a remarkable 0.41% increase in its share price. This surge in value has sparked heightened investor interest, with the stock currently trading at ₹1,658.50 per share. The stock has an ROE of 15.1334% and debt to equity ratio of 0.0327.

Investors are buzzing as Sun Pharmaceutical Industries Ltd's share price soared by an impressive 0.02%. At this moment, it's actively trading at ₹1,651.80, presenting an enticing opportunity for those in the market.

After a -0.03% decline, Sun Pharmaceutical Industries Ltd shares are now trading at ₹1,653.25. The stock has a PE ratio of 36.6700, an ROE of 15.1334% and a debt to equity ratio of 0.0327.

Sun Pharmaceutical Industries Ltd witnessed a -0.05% drop in its share price and is currently trading at ₹1,653.95. With the stock's PE at 36.6700 and the industry PE at 34.2321, investors are weighing their options.

The stock of Sun Pharmaceutical Industries Ltd has experienced a -0.23% drop, and it's now trading at ₹1,653.70 per share. This decline has sparked discussions within the investment community regarding the stock's future prospects.

Sun Pharmaceutical Industries Ltd observed a -0.14% decrease in its share price, a situation that merits attention. As of now, it's actively trading at ₹1,657.50. The stock has a PE ratio of 36.6700, an ROE of 15.1334% and a debt to equity ratio of 0.0327.

The stock of Sun Pharmaceutical Industries Ltd has experienced a -0.39% drop, and it's now trading at ₹1,659.80 per share. This decline has sparked discussions within the investment community regarding the stock's future prospects.

Sun Pharmaceutical Industries Ltd's share price has dropped by -0.23%, a development that warrants careful analysis. Presently trading at ₹1,666.10, investors are assessing whether this presents an opportunity or a risk.

Sun Pharmaceutical Industries Ltd witnessed a -0.16% drop in its share price and is currently trading at ₹1,669.90. With the stock's PE at 36.6700 and the industry PE at 34.2321, investors are weighing their options.

Increased investor interest has propelled Sun Pharmaceutical Industries Ltd's stock to a significant 0.05% gain, with the share price now at ₹1,672.50. Notably, the stock's PE ratio stands at 36.6700, and its Return on Equity (ROE) is 15.1334%.

After a -0.47% decline, Sun Pharmaceutical Industries Ltd shares are now trading at ₹1,671.00. The stock has a PE ratio of 36.6700, an ROE of 15.1334% and a debt to equity ratio of 0.0327.

Sun Pharmaceutical Industries Ltd witnessed a notable 0.51% surge in its share price and is presently trading at ₹1,678.85, captivating the attention of market participants.